{"nct_id":"NCT06062420","title":"A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2023-11-14","start_date_type":"ACTUAL","primary_completion_date":"2027-05-14","primary_completion_date_type":"ESTIMATED","completion_date":"2027-05-14","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}